Search Results
Search for other papers by Chiara Verdelli in
Google Scholar
PubMed
Search for other papers by Irene Forno in
Google Scholar
PubMed
Endocrine Surgery, IRCCS Ospedale San Raffaele, Milan, Italy
Search for other papers by Annamaria Morotti in
Google Scholar
PubMed
Search for other papers by Riccardo Maggiore in
Google Scholar
PubMed
Search for other papers by Gilberto Mari in
Google Scholar
PubMed
Search for other papers by Leonardo Vicentini in
Google Scholar
PubMed
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
Search for other papers by Stefano Ferrero in
Google Scholar
PubMed
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
Search for other papers by Elisabetta Kuhn in
Google Scholar
PubMed
Division of Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Search for other papers by Valentina Vaira in
Google Scholar
PubMed
Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy
Search for other papers by Sabrina Corbetta in
Google Scholar
PubMed
parathyroid tumors include miRNAs involved in angiogenesis. In particular, previous reports described that miR-126-3p and miR-126-5p were reduced in parathyroid carcinomas compared with adenomas, while they did not consider miR-126-3p expression in normal
Search for other papers by Päivi Järvensivu in
Google Scholar
PubMed
Search for other papers by Taija Heinosalo in
Google Scholar
PubMed
Search for other papers by Janne Hakkarainen in
Google Scholar
PubMed
Search for other papers by Pauliina Kronqvist in
Google Scholar
PubMed
Search for other papers by Niina Saarinen in
Google Scholar
PubMed
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
determined in 4-month-old HSD17B1TG and WT females. Radioactive [ 3 H]-E1 (Perkin Elmer) dissolved in ethanol:saline (20:80 by vol.) was slowly injected i.v. (2.5 μL/g, 1.6 Mbq/mouse). Mice were terminally anesthetized with tribromoethanol (Avertin, 600
David Geffen School of Medicine, University of California – Los Angeles, Los Angeles, California, USA
Search for other papers by Andrew G Gianoukakis in
Google Scholar
PubMed
Search for other papers by Corina E Dutcus in
Google Scholar
PubMed
Search for other papers by Nicolas Batty in
Google Scholar
PubMed
Search for other papers by Matthew Guo in
Google Scholar
PubMed
Search for other papers by Mahadi Baig in
Google Scholar
PubMed
with greater disease burden (tumor size ≤35 mm: 44.3 months; 35–60 mm: 27.5 months; 60–92 mm: 18.0 months; >92 mm: 15.7 months), patients with liver metastasis (yes: 15.7 months; no: 30.5 months) and patients with brain metastasis (yes: 9.3 months; no
Search for other papers by Andres Elía in
Google Scholar
PubMed
Search for other papers by Leo Saldain in
Google Scholar
PubMed
Search for other papers by Silvia Lovisi in
Google Scholar
PubMed
Search for other papers by Paula Martínez Vazquez in
Google Scholar
PubMed
Search for other papers by Javier Burruchaga in
Google Scholar
PubMed
Search for other papers by Caroline A Lamb in
Google Scholar
PubMed
Search for other papers by Isabel Alicia Lüthy in
Google Scholar
PubMed
Search for other papers by Federico Diez in
Google Scholar
PubMed
Search for other papers by Natalie Z M Homer in
Google Scholar
PubMed
Search for other papers by Ruth Andrew in
Google Scholar
PubMed
Search for other papers by Paola Rojas in
Google Scholar
PubMed
Search for other papers by Claudia Lanari in
Google Scholar
PubMed
15 mm, (iii) PRA/PRB ratios higher than 1.5 determined by Western blot, (iv) PR total levels ≥50% evaluated by immunohistochemistry, (v) World Health Organization condition of 1 with the adequate function of organs and systems: absolute neutrophil
Centre for Endocrinology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK
Search for other papers by Nicola Tufton in
Google Scholar
PubMed
Search for other papers by Rahul Ghelani in
Google Scholar
PubMed
Search for other papers by Umasuthan Srirangalingam in
Google Scholar
PubMed
Search for other papers by Ajith V Kumar in
Google Scholar
PubMed
Department of Endocrinology, Southampton General Hospital, University Hospital Southampton NHS Trust, Southampton, Hampshire, UK
Search for other papers by William M Drake in
Google Scholar
PubMed
Search for other papers by Donato Iacovazzo in
Google Scholar
PubMed
Search for other papers by Kassiani Skordilis in
Google Scholar
PubMed
Search for other papers by Daniel Berney in
Google Scholar
PubMed
Search for other papers by Ma’en Al-Mrayat in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Search for other papers by Scott A Akker in
Google Scholar
PubMed
a 5 cm para-adrenal PGL, which was subsequently resected. He developed a symptomatic recurrence one year later, which was surgically resected. Eight years after his original diagnosis, he presented with symptoms of catecholamine excess and four new
Department of Disaster Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan
Search for other papers by Kiyoshi Ito in
Google Scholar
PubMed
Search for other papers by Yasuhiro Miki in
Google Scholar
PubMed
Search for other papers by Takashi Suzuki in
Google Scholar
PubMed
Search for other papers by Keely May McNamara in
Google Scholar
PubMed
Search for other papers by Hironobu Sasano in
Google Scholar
PubMed
), androstenedione (A4), testosterone and 5α-dihydrotestosterone (DHT), were significantly associated with an increased risk of developing endometrial carcinoma ( Potischman et al . 1996 , Kaaks et al . 2002 , Lukanova et al . 2004 , Allen et al . 2008
Search for other papers by Toyoshi Endo in
Google Scholar
PubMed
Search for other papers by Tetsuro Kobayashi in
Google Scholar
PubMed
-stimulating hormone (TSH; Nikiforov & Nikiforova 2011 ). The RET/PTC rearrangement and the BRAF V600E point mutation are the two most common genetic alterations associated with PTCs; the prevalence of RET/PTC varies from 2.5 to 78% ( Zou et al . 1994
Search for other papers by Katarina Edfeldt in
Google Scholar
PubMed
Search for other papers by Tanveer Ahmad in
Google Scholar
PubMed
Search for other papers by Göran Åkerström in
Google Scholar
PubMed
Search for other papers by Eva Tiensuu Janson in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Gunnar Westin in
Google Scholar
PubMed
are increasing. The tumors are small (often <2 cm) and slow growing (Ki67 proliferation index is often <2%), but still have a lethal outcome with a 5-year survival rate around 65% ( Yao et al . 2008 , Norlen et al . 2012 ). Many patients have tumor
Search for other papers by Sílvia F Sousa in
Google Scholar
PubMed
Search for other papers by Ricardo S Gomez in
Google Scholar
PubMed
Search for other papers by Marina G Diniz in
Google Scholar
PubMed
Search for other papers by Vanessa F Bernardes in
Google Scholar
PubMed
Search for other papers by Flávia F C Soares in
Google Scholar
PubMed
Search for other papers by João Artur R Brito in
Google Scholar
PubMed
Search for other papers by Sophie Liu in
Google Scholar
PubMed
Search for other papers by Hélder Antônio R Pontes in
Google Scholar
PubMed
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
Search for other papers by Carolina C Gomes in
Google Scholar
PubMed
after all of the skin had been removed and they had been fixed in 4% paraformaldehyde (PFA). Bony structures were slowly decalcified with EDTA 0.9 M at pH 7.5 over a period of 20 days, rinsed with distilled water, sectioned, paraffin embedded, and H&E
Search for other papers by Irasema Mendieta in
Google Scholar
PubMed
Search for other papers by Gabriel Rodríguez-Gómez in
Google Scholar
PubMed
Search for other papers by Bertha Rueda-Zarazúa in
Google Scholar
PubMed
Search for other papers by Julia Rodríguez-Castelán in
Google Scholar
PubMed
Search for other papers by Winniberg Álvarez-León in
Google Scholar
PubMed
Search for other papers by Evangelina Delgado-González in
Google Scholar
PubMed
Search for other papers by Brenda Anguiano in
Google Scholar
PubMed
Search for other papers by Olivia Vázquez-Martínez in
Google Scholar
PubMed
Search for other papers by Mauricio Díaz-Muñoz in
Google Scholar
PubMed
Search for other papers by Carmen Aceves in
Google Scholar
PubMed
of the highest purity grade commercially available. Cell culture The NB cell lines SH-SY5Y (CRL-2266), SK-N-BE(2) (CRL-2271), and SK-N-AS (CRL-2137) were obtained from American Type Culture Collection (ATCC), passage 1–5, and recently tested